Ohtuvayre (Ensifentrine) - What are the side effects of Ensifentrine?

Ohtuvayre (Ensifentrine)-Ensefentine is a new drug used to treat chronic obstructive pulmonary disease (COPD) in adults. Although it has shown good efficacy in clinical studies, it is also accompanied by certain adverse reactions. Common side effects of Ohtuvayre include back pain, high blood pressure, urinary tract infections and diarrhea, according to clinical trial results. The occurrence of these adverse reactions may affect the patient's medication experience, so special attention is required when using this drug.

In addition to the common side effects mentioned above, Ohtuvayre may also cause some more serious reactions. For example, patients may experience an acute episode of bronchospasm or paradoxical bronchospasm, which is a potential risk for patients with preexisting respiratory conditions. In addition, psychotic events are also among the warnings and precautions mentioned in clinical studies. Although these events are relatively rare, they can have a significant impact on a patient's mental health and overall well-being. Therefore, doctors need to fully assess the patient's medical history when prescribing.

OveruseOhtuvayre may also cause a series of uncomfortable symptoms, including headache, tachycardia and palpitations. These symptoms not only affect the patient's daily life, but may also lead to more serious health problems. Therefore, patients must strictly follow their doctor's instructions when taking medications to avoid overdose.

Once an overdose occurs, timely treatment is crucial. Treatment usually involves temporary discontinuation of exefantine and implementation of appropriate symptomatic supportive therapy. This means that doctors will take appropriate measures based on a patient's specific symptoms to reduce the patient's discomfort and ensure their safety. In addition, doctors should closely monitor the patient's condition to ensure that no further complications develop.

Reference materials:https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e6433c98-41a0-4f99-8f7f-d0e9db6e3f40